Post-marketing surveillance of nimesulide suspension.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D002648:Child; D006801:Humans; D007194:India; D011358:Product Surveillance, Postmarketing; D013449:Sulfonamides / Q000009:adverse effects*; D013535:Suspensions
D000894:Anti-Inflammatory Agents, Non-Steroidal; D013449:Sulfonamides; D013535:Suspensions; C012655:nimesulide